Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.
Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy
Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA
Insight in to the EMILIA trial and systemic challenges with neoadjuvant therapy ( Dr Erica Mayer - Dana-Farber Cancer Institute, Boston, MA, USA )
19 Jun 2012
Drug development in small cell and non-small cell lung cancer
Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA
Drug development in small cell and non-small cell lung cancer ( Dr Leora Horn - Vanderbilt-Ingram Cancer Center, Nashville, USA  )
18 Jun 2012
Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma
Dr Sagar Lonial – Emory University, Atlanta, USA
Early phase 1/2 results with oral proteasome inhibitor MLN9708 in myeloma ( Dr Sagar Lonial – Emory University, Atlanta, USA )
15 Jun 2012
Effects of panitumumab against oesophageal-gastro cancer and carcinomas
Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK
Effects of panitumumab against oesophageal-gastro cancer and carcinomas ( Dr Tom Waddell – Royal Marsden Hospital, Sutton, UK )
15 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved targ...
Dr George Demetri - Dana-Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George	 Demetri - Dana-Farber Cancer Institute, Boston, USA )
13 Jun 2012
ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma
Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Mathias Rum...
ASCO 2012: Advances in lymphoma; bendamustine combination in indolent lymphoma ( Prof John Gribben - Barts & The London Trust Cancer Centre, UK; Prof Mathias Rummel - University Hospital Giessen, Germany )
12 Jun 2012
ASCO 2012: Advances in metastatic castration-resistant prostate cancer; first-li...
Dr Chris Parker - Royal Marsden Cancer Centre, London, UK; Prof Stéphan Oudard -...
ASCO 2012: Advances in metastatic castration-resistant prostate cancer; first-line cabazitaxel ( Dr Chris Parker - Royal Marsden Cancer Centre, London, UK; Prof Stéphan Oudard - Hôpital Européen Georges Pompidou, France )
12 Jun 2012
Increased risk of breast cancer among young women treated with radiation as a ch...
Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA
Increased risk of breast cancer among young women treated with radiation as a child ( Dr Chaya Moskowitz - Memorial Sloan-Kettering Cancer Center, New York, USA )
4 Jun 2012
First effective treatment for chemotherapy-induced peripheral neuropathy
Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA
First effective treatment for chemotherapy-induced peripheral neuropathy ( Dr Ellen Lavoie Smith - University of Michigan, Ann Arbor, USA )
4 Jun 2012
Regorafenib effective for GISTs that progress due to resistance to approved targ...
Dr George Demetri - Dana Farber Cancer Institute, Boston, USA
Regorafenib effective for GISTs that progress due to resistance to approved targeted therapies ( Dr George Demetri - Dana Farber Cancer Institute, Boston, USA )
4 Jun 2012
Combined chemo-radiation extends survival in patients with anaplastic oligodendr...
Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlan...
Combined chemo-radiation extends survival in patients with anaplastic oligodendroglial tumours ( Dr Martin Van Den Bent - Erasmus University Medical Center, Rotterdam, Netherlands )
3 Jun 2012
Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improve...
Dr Eric Pujade-Lauraine - Université Paris Descartes, France
Adding bevacizumab to chemotherapy for platinum-resistant ovarian cancer improves progression-free survival ( Dr Eric Pujade-Lauraine - Université Paris Descartes, France )
2 Jun 2012